NSAID in short supply following Hospira recall

NSAID in short supply following Hospira recall | American Pharmacists Association Skip to main content

Advertisement

Connect Contact UsLogin/Register Join APhA Search form Search Advanced Search LEARNPRACTICEGET INVOLVEDSHOP ABOUTNEWS Search form Search Advanced Search LEARNPRACTICEGET INVOLVEDSHOP ABOUTNEWS Menu LEARNCAREER CENTERJOB SEARCHPATHWAYSRESIDENCIESCONTINUING EDUCATIONHOME STUDY CPELIVE ACTIVITIESTRAINING PROGRAMSAMBULATORY CARE REVIEW AND RECERTIFICATIONTECHNICIANSMY TRAININGPRACTICEMTM CENTRALIMPLEMENTING MTM IN YOUR PRACTICEADVANCING THE VALUE OF MTMMTM RESOURCE LIBRARYIMMUNIZATION CENTERAPhA IMMUNIZATION GUIDELINESADMINISTRATION TECHNIQUEASK THE EXPERTSINFECTIOUS DISEASECOMPOUNDINGFREQUENTLY ASKED QUESTIONSSPECIALTY PHARMACYTOPICS IN PRACTICEPATIENT OUTREACH TOOLSSAFETY NET PROVIDERSAPPOINTMENT BASED MODELGET INVOLVEDPARTICIPATEHOUSE OF DELEGATESAPhA-APPMAPhA-APRSAPhA-ASPNEW PRACTITIONER NETWORKELECTIONSANNUAL MEETING & EXPOSITIONJOINT FEDERAL PHARMACY SEMINARAWARDSJOIN APhAWHY JOIN APhA?RENEW YOUR MEMBERSHIPAPhA CORPORATE SUPPORTERSUSING YOUR APhA BENEFITSADVOCATEISSUESACTIONAPhA-PACPROVIDER STATUSENGAGE COMMUNITIESAMERICAN PHARMACISTS MONTHSHOPSHOP APhA PRODUCTSAPhA E-BOOKSFACULTY RESOURCESLEXICOMP PRODUCTSCORRECTIONS ABOUTWHO WE AREHISTORY OF APhAGOVERNANCE AND LEADERSHIPAPhA DEPARTMENT CONTACTSEXTERNAL SUPPORTEMPLOYMENTTHE PHARMACY PROFESSIONGETTING THE MOST FROM YOUR PHARMACISTNEWSPHARMACY TODAYABOUTDIGITAL READERCURRENT ISSUEPAST ISSUESINFORMATIONAL RESOURCESLETTERS TO THE EDITORADVERTISESUBSCRIBESTUDENT PHARMACISTDIGITAL READERCURRENT ISSUEPAST ISSUESADVERTISEAPhA DRUGINFOLINEJAPhAJPHARMSCICEO BLOGMEDIA RESOURCESAPhA TV NEWS PHARMACY TODAYABOUTDIGITAL READERCURRENT ISSUEPAST ISSUESINFORMATIONAL RESOURCESLETTERS TO THE EDITORADVERTISESUBSCRIBESTUDENT PHARMACISTDIGITAL READERCURRENT ISSUEPAST ISSUESADVERTISEAPhA DRUGINFOLINEJAPhAJPHARMSCICEO BLOGMEDIA RESOURCESAPhA TV Experience Select One That Best Describes you Student Practitioner Scientist Advertisement

NSAID in short supply following Hospira recall Share This Page
  February 13, 2015Hospira's recall of more than 60 lots of ketorolac tromethamine is leading to shortages in some hospitals. The company alerted customers in January that it was voluntarily recalling the injectable NSAID after receiving a report of floating particulates, identified as calcium-ketorolac crystals.

Hospira's recall of more than 60 lots of ketorolac tromethamine is leading to shortages in some hospitals. The company alerted customers in January that it was voluntarily recalling the injectable NSAID after receiving a report of floating particulates, identified as calcium-ketorolac crystals. The recalled lots were distributed in the United States from February 2013 to December 2014, and in Singapore from January to July 2014. Hospira has provided about 95% of the U.S. supply of ketorolac, and Fresenius Kabi, which supplies the remaining share, reports that it is increasing production of its version of ketorolac. FDA has added both companies' versions of the drug to its list of drugs in short supply ? Hospira's due to the recall and Fresenius Kabi's due to the increased demand. Edward Michna, MD, a board member of the American Pain Society and an anesthesiologist at Brigham and Women's Hospital in Boston, suggests that one alternative is to give patients more opioids, while another possible option is diclofenac sodium (Dyloject?Hospira), an injectable NSAID that FDA approved in December.

Wall Street Journal (02/12/15) Loftus, Peter

Ad Position: Bottom-Right http://www.wsj.com/articles/painkiller-in-short-supply-following-hospira-recall-1423774295?KEYWORDS=hospira+recall Advertisement

Related Content

block-views-related-content-block  Back to Top LEARNCAREER CENTERCONTINUING EDUCATIONPRACTICEMTM CENTRALIMMUNIZATION CENTERINFECTIOUS DISEASECOMPOUNDINGSPECIALTY PHARMACYTOPICS IN PRACTICEAPPOINTMENT BASED MODELGET INVOLVEDPARTICIPATEJOIN APhAADVOCATEPROVIDER STATUSENGAGE COMMUNITIESAMERICAN PHARMACISTS MONTHSHOPSHOP APhA PRODUCTSAPhA E-BOOKSFACULTY RESOURCESLEXICOMP PRODUCTSCORRECTIONS MEMBER CENTERTHE APhA FOUNDATIONPHARMACY LIBRARYBUYERS GUIDE

2215 Constitution Avenue NW, Washington, DC 20037? 2015 American Pharmacists Association All Rights Reserved.tel. 202.628.4410fax 202.783.2351SitemapPrivacy Policy Terms of Use View in Desktop ModeLogin/Register   PHARMACY TODAYABOUTDIGITAL READERCURRENT ISSUEPAST ISSUESINFORMATIONAL RESOURCESLETTERS TO THE EDITORADVERTISESUBSCRIBESTUDENT PHARMACISTDIGITAL READERCURRENT ISSUEPAST ISSUESADVERTISEAPhA DRUGINFOLINEJAPhAJPHARMSCICEO BLOGMEDIA RESOURCESAPhA TV Featured  Policy 101: Medically underserved communities   Olaparib: new drug for advanced ovarian cancer

 

CAREER CENTERJOB SEARCHPATHWAYSRESIDENCIESCONTINUING EDUCATIONHOME STUDY CPELIVE ACTIVITIESTRAINING PROGRAMSAMBULATORY CARE REVIEW AND RECERTIFICATIONTECHNICIANSMY TRAINING FeaturedOur profession's storytellers get the word out!

Pharmacist license revocation reversed

 

MTM CENTRALIMPLEMENTING MTM IN YOUR PRACTICEADVANCING THE VALUE OF MTMMTM RESOURCE LIBRARYIMMUNIZATION CENTERAPhA IMMUNIZATION GUIDELINESADMINISTRATION TECHNIQUEASK THE EXPERTSINFECTIOUS DISEASECOMPOUNDINGFREQUENTLY ASKED QUESTIONSSPECIALTY PHARMACYTOPICS IN PRACTICEPATIENT OUTREACH TOOLSSAFETY NET PROVIDERSAPPOINTMENT BASED MODEL FeaturedNew Mexican pharmacists create care transitions program
 

Choe enhances health care for Michigan patients PARTICIPATEHOUSE OF DELEGATESAPhA-APPMAPhA-APRSAPhA-ASPNEW PRACTITIONER NETWORKELECTIONSANNUAL MEETING & EXPOSITIONJOINT FEDERAL PHARMACY SEMINARAWARDSJOIN APhAWHY JOIN APhA?RENEW YOUR MEMBERSHIPAPhA CORPORATE SUPPORTERSUSING YOUR APhA BENEFITSADVOCATEISSUESACTIONAPhA-PACPROVIDER STATUSENGAGE COMMUNITIESAMERICAN PHARMACISTS MONTH Featured Give clear, explicit directions to patientsPharmacist Aldrich reduces readmissions, incorrect med usage in NM

 

SHOP APhA PRODUCTSAPhA E-BOOKSFACULTY RESOURCESLEXICOMP PRODUCTSCORRECTIONS Featured Pharmacy Technician Skills-Building Manual 

 

WHO WE AREHISTORY OF APhAGOVERNANCE AND LEADERSHIPAPhA DEPARTMENT CONTACTSEXTERNAL SUPPORTEMPLOYMENTTHE PHARMACY PROFESSIONGETTING THE MOST FROM YOUR PHARMACIST Featured  APhA2015: Let's advance as one!Today's Perspective: Remembering the basics

 

View the original article here